第一届全国射波刀研讨会第三轮通知第三轮通知.pptxVIP

第一届全国射波刀立体定向放射治疗研讨会 暨全国射波刀治疗协作组成立大会 ; 医院简介 天津医科大学附属肿瘤医院前身为英国伦敦会施医院，始建于1861年，是我国肿瘤学科的发祥地，是集医、教、研、防为一体的大型三级甲等肿瘤专科医院，是我国最大的肿瘤防治研究基地之一。医院占地面积6.2万平方米，设有40个临床医技科室，开放床位2400张，拥有百万元以上大型诊疗设备53台套。医院肿瘤学科是国家重点学科，国家“211工程”重点建设学科。医院附设天津市肿瘤研究所，并拥有肿瘤临床学院、国家临床药理基地、国家继续医学教育基地及“乳腺癌防治”教育部重点实验室。中国抗癌协会总部、国家一级核心刊物《中国肿瘤临床》均挂靠我院。医院还是国际抗癌联盟（UICC）会员单位。 Introduction Tianjin Medical University Cancer Institute Hospital (TMUCIH) was founded in 1861 as the British Army Hospital. It is the birthplace of Oncology in China and is a large highly specialized cancer facility with integrated patient care, education，training, research and prevention activities. It is one of the top cancer facilities in China and provide cancer treatment not only to people in Tianjin and northern part of China, but also other regions of China as well as foreign patients. It is also one of the largest prevention and research bases of Oncology in China. TMUCIH covers area of 62,000 square meters and has 40 clinical and diagnostic departments and has 2400 beds. The hospital has equipped more than 53 advanced facilities and systems for cancer diagnoses and treatment. The TMUCIH Oncology Research Program is one of the key nationally designated programs, which has been supported by the national “Project 211”.Tianjin Cancer Institute affiliated to the Hospital. TMUCIH is the Academy of Clinical Oncology; the designated Base for Clinical Pharmacology by the State Food and Drug Administration; the State Base of Continuing Medical Education designated by Ministry of Public Health; The “Treatment and prevention Laboratory for Breast Cancer” is a Key Laboratory designated by the State Ministry of Education. TMUCIH is the home for the editorial office of the Chinese Journal of Clinical Oncology (CJCO). The Chinese Anti-Cancer Association (CACA) is also located in the hospital. TMUCIH is also the member of Union for International Cancer Control (UICC). ;尊敬的各位专家、同道们： 大家好！ 近年来，射波刀技术日益普及。伴随新技术的进步，肿瘤放射治疗迎来极大的发展空间和机遇。为